Brief: Neubase Therapeutics Reports Business Update And Financial Results For Q1 2023
14/02/2023 21:27
Feb 14 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS REPORTS BUSINESS UPDATE AND FINANCIAL
RESULTS FOR THE FIRST QUARTER OF FISCAL YEAR 2023
* NEUBASE THERAPEUTICS INC Q1 LOSS PER SHARE $0.13
* NEUBASE THERAPEUTICS - ESTIMATES CURRENT CASH, CASH
EQUIVALENTS
SUFFICIENT TO FUND CURRENTLY PLANNED OPERATING AND CAPITAL
EXPENDITURES INTO Q2 CY24
Source text for Eikon: ID:nGNX5tHTyg
Further company coverage: NBSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet